Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
TNS Energo Voronezh reported for 2024 by RAS
4/1/25
VRSB
Rusal reported for 2024 by RAS
4/1/25
RUAL
ChZPSN-Profnastil reported for 2024 by RAS
4/1/25
PRFN
UWC reported for 2024 by RAS
3/31/25
UWGN
Globaltrak reported for 2024 by RAS
3/31/25
GTRK
SFI transferred its stake in M.Video to subsidiary SFI Capital
3/31/25
SFIN
SFI transferred its stake in M.Video to subsidiary SFI Capital
3/31/25
MVID
EL5-Energo reported for 2024 by IFRS
3/31/25
ELFV
Seligdar reports for 2024 by RAS
3/31/25
SELG
United Medical Group reported for 2024 by IFRS
3/31/25
GEMC
«
Previous
59
60
61
62
63
64
65
66
67
68
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 